Galanin hyperinnervates surviving neurons of the human basal nucleus of meynert in dementias of alzheimer's and parkinson's disease: A hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia

Journal of Comparative Neurology

Volumn 273, Issue 4, 1988, Pages 543-557

  Chan Palay V ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

axonal nets; cholinergic neurons; hypertrophy; plasticity; therapy

Indexed keywords

GALANIN;

ADULT; AGED; ALZHEIMER DISEASE; AUTOPSY; CHOLINERGIC SYSTEM; DEMENTIA; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MEYNERT BASAL NUCLEUS; PARKINSON DISEASE; PRIORITY JOURNAL;

ACETYLCHOLINE; ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BASAL GANGLIA; BRAIN; FEMALE; GALANIN; HUMAN; MALE; MIDDLE AGE; NEURONS; NEUROPEPTIDES; PARKINSON DISEASE; PEPTIDES; SUBSTANTIA INNOMINATA;

EID: 0023728879     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.902730409     Document Type: Article

References (53)

1. An analysis of the origins of the cholinergic and noncholinergic septal projections to the hippocampal formation of the rat
2. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients
3. Cholinomimetic treatment fails to improve memory disorders (Letter to the editor). N
4. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases
5. Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: Coexistence with neuropeptide Y neurons, and effects in Alzheimer‐type dementia
6. Neurons with galanin innervate cholinergic cells in the human basal forebrain and galanin and acetylcholine coexist
7. II. Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's‐type dementia
8. Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's type dementia
9. Distribution of galanin immunoreactivity in the central nervous system and the response of galanin containing neuronal pathways to injury
10. Physostigmine and areocoline: Effects of intravenous infusions in Alzheimer presenile dementia
11. Selective loss of central cholinergic neurons in Alzheimer's disease
12. Enhancement of memory processes in Alzheimer's disease with multiple‐dose intravenous physostigmine
13. Dementia and Parkinson's disease: Biochemical and anatomoclinical correlation
14. Production of specific antisera and monoclonal antibodies to choline acetyltransferase: Characterization and use for identification of cholinergic neurons
15. Alzheimer disease: Lack of effect of lecithin treatment for 3 months
16. The nucleus basalis of Meynert
17. Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: Histochemical, autoradiographic, in vivo, and in vitro studies
18. Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases
19. Preliminary report: Intracranial cholinergic drug infusion in patients with Alzheimer's disease
20. Topographic atlas of catecholamine and acetylcholinesterase containing neurons in the rat brain. I. Forebrain (Telencephalon, Diencephalon)
21. The central cholinergic system studied by choline acetyltransferase immunohistochemistry in the rat
22. Choline acetyltransferase containing neurons in rodent brain demonstrated by immunohistochemistry
23. Septal neurons containing glutamic acid decarboxylase immunoreactivity project to the hippocampal region in the rat brain
24. Galanin immunoreactivity in hypothalamic histamine neurons: Further evidence for multiple chemical messengers in the tuberomammillary nucleus
25. Galanin: Stimulation of feeding induced by medial hypothalamic injection of this novel peptide
26. The cholinergic limbic system: Projections to hippocampal formation, medial cortex, nuclei of the ascending cholinergic reticular system, and the subfornical organ and supraopticcrest
27. Mental impairment in Parkinson's disease. The role of anticholinergic drugs
28. Distribution of galanin‐like immunoreactivity in the rat central nervous system
29. A galanin‐like peptide coexists in putative cholinergic somata in the septum‐basal forebrain complex and in acetylcholinesterase containing fibers and varicosities within the hippocampus in the owl monkey (Aotus trivirgatus)
30. Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey
31. The brain of mammals
32. A memory system in the monkey
33. Galanin: Evidence for a hypothalamic site of action to release growth hormone
34. Cholinergic correlates of cognitive impairment in Parkinson's disease: Comparisons with Alzheimer's disease
35. Pharmacologic treatment of Alzheimer's disease: Future directions
36. The nucleus basalis of Meynert in neurological disease: A quantitative morphological study
37. Neurochemical characteristics of early and late onset types of Alzheimer's disease
38. Immunohistochemical mapping of galanin‐like neurons in the rat central nervous system
39. Topography of choline acetyltransferase‐containing neurons in the forebrain of the rat
40. Use of THA in treatment of Alzheimer‐like dementia: Pilot study in twelve patients
41. The connections of the septal region in the rat
42. Galanin–A novel biologically active peptide from porcine intestine
43. Choline chloride fails to improve cognition in Alzheimer's disease
44. Galanin‐containing somata in the primate nucleus basalis/diagonal band complex
45. Basal forebrain cholinergic neurons and Alzheimer's disease
46. Effects of 4‐aminopyridine in elderly patients with Alzheimer's disease (letter to the editor)
47. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain
48. Alzheimer's disease: Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities
49. Parkinson's disease and dementia
50. Monoclonal antibodies of GABA and acetylcholine synthesizing enzymes
51. Immunoaffinity purification of GAD‐arylglutamate decarboxylase and cholinacetyltransferase
52. Evidence for galanin as an inhibitory neuropeptide on myenteric cholinergic neurons in the guineapig small intestine